FKC - Belleair Dialysis Center is a medicare approved dialysis facility center in Clearwater, Florida and it has 20 dialysis stations. It is located in Pinellas county at 617 Lakeview Road Suite B, Clearwater, FL, 33756. You can reach out to the office of FKC - Belleair Dialysis Center at (727) 441-8590. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FKC - Belleair Dialysis Center has the following ownership type - Profit. It was first certified by medicare in August, 2006. The medicare id for this facility is 102835 and it accepts patients under medicare ESRD program.
| Name | FKC - Belleair Dialysis Center |
|---|---|
| Location | 617 Lakeview Road Suite B, Clearwater, Florida |
| No. of Dialysis Stations | 20 |
| Medicare ID | 102835 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 617 Lakeview Road Suite B, Clearwater, Florida, 33756 | |
| (727) 441-8590 | |
| Not Available |
News Archive
Many risk factors for breast cancer are well studied and documented. Thus, scientists are sure by now that early first menstrual period, late onset of menopause and a family history of breast cancer are associated with an increased breast cancer risk.
To celebrate and reflect on the scientific achievements of one of Europe's most successful Networks of Excellence, and to launch the newly formed Med-Vet-Net Association — the future incarnation of the Med-Vet-Net partnership that will forge ahead with research tackling the zoonoses and food-borne diseases that threaten the public health of the European Community.
Texas plans to invest $3 billion in cancer research over the next 10 years and six scientists at The University of Texas Health Science Center at Houston are among the first to receive grants.The researchers, whose grants total $4.5 million, are working to protect girls from cervical cancer, to interrupt tumor growth at the molecular level and to develop a new approach for the treatment of colon cancer, among other cutting-edge projects.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center. APS is the leading multidisciplinary professional organization in the United States dedicated to advancing pain-related research, education, treatment and team-oriented professional practice.
Cancer Research UK-funded scientists have shown how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer, according to a study published in Nature.
› Verified 6 days ago
| NPI Number | 1588689152 |
| Doing Business As | The Kidney Group Of Clearwater, Llc |
| Address | 617 Lakeview Rd Clearwater, Florida, 33756 |
| Phone Number | (727) 441-8590 |
News Archive
Many risk factors for breast cancer are well studied and documented. Thus, scientists are sure by now that early first menstrual period, late onset of menopause and a family history of breast cancer are associated with an increased breast cancer risk.
To celebrate and reflect on the scientific achievements of one of Europe's most successful Networks of Excellence, and to launch the newly formed Med-Vet-Net Association — the future incarnation of the Med-Vet-Net partnership that will forge ahead with research tackling the zoonoses and food-borne diseases that threaten the public health of the European Community.
Texas plans to invest $3 billion in cancer research over the next 10 years and six scientists at The University of Texas Health Science Center at Houston are among the first to receive grants.The researchers, whose grants total $4.5 million, are working to protect girls from cervical cancer, to interrupt tumor growth at the molecular level and to develop a new approach for the treatment of colon cancer, among other cutting-edge projects.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center. APS is the leading multidisciplinary professional organization in the United States dedicated to advancing pain-related research, education, treatment and team-oriented professional practice.
Cancer Research UK-funded scientists have shown how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer, according to a study published in Nature.
› Verified 6 days ago
| NPI Number | 1962728006 |
| Organization Name | Fresenius Medical Care Of Belleair Dialysis Center |
| Doing Business As | Bio-medical Applications Of Florida Inc |
| Address | 617 Lakeview Rd Clearwater, Florida, 33756 |
| Phone Number | (727) 441-8590 |
News Archive
Many risk factors for breast cancer are well studied and documented. Thus, scientists are sure by now that early first menstrual period, late onset of menopause and a family history of breast cancer are associated with an increased breast cancer risk.
To celebrate and reflect on the scientific achievements of one of Europe's most successful Networks of Excellence, and to launch the newly formed Med-Vet-Net Association — the future incarnation of the Med-Vet-Net partnership that will forge ahead with research tackling the zoonoses and food-borne diseases that threaten the public health of the European Community.
Texas plans to invest $3 billion in cancer research over the next 10 years and six scientists at The University of Texas Health Science Center at Houston are among the first to receive grants.The researchers, whose grants total $4.5 million, are working to protect girls from cervical cancer, to interrupt tumor growth at the molecular level and to develop a new approach for the treatment of colon cancer, among other cutting-edge projects.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center. APS is the leading multidisciplinary professional organization in the United States dedicated to advancing pain-related research, education, treatment and team-oriented professional practice.
Cancer Research UK-funded scientists have shown how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer, according to a study published in Nature.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 46 |
News Archive
Many risk factors for breast cancer are well studied and documented. Thus, scientists are sure by now that early first menstrual period, late onset of menopause and a family history of breast cancer are associated with an increased breast cancer risk.
To celebrate and reflect on the scientific achievements of one of Europe's most successful Networks of Excellence, and to launch the newly formed Med-Vet-Net Association — the future incarnation of the Med-Vet-Net partnership that will forge ahead with research tackling the zoonoses and food-borne diseases that threaten the public health of the European Community.
Texas plans to invest $3 billion in cancer research over the next 10 years and six scientists at The University of Texas Health Science Center at Houston are among the first to receive grants.The researchers, whose grants total $4.5 million, are working to protect girls from cervical cancer, to interrupt tumor growth at the molecular level and to develop a new approach for the treatment of colon cancer, among other cutting-edge projects.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center. APS is the leading multidisciplinary professional organization in the United States dedicated to advancing pain-related research, education, treatment and team-oriented professional practice.
Cancer Research UK-funded scientists have shown how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer, according to a study published in Nature.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 100 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 802 |
| Percentage of adult patients getting regular hemodialysis at the center | |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Many risk factors for breast cancer are well studied and documented. Thus, scientists are sure by now that early first menstrual period, late onset of menopause and a family history of breast cancer are associated with an increased breast cancer risk.
To celebrate and reflect on the scientific achievements of one of Europe's most successful Networks of Excellence, and to launch the newly formed Med-Vet-Net Association — the future incarnation of the Med-Vet-Net partnership that will forge ahead with research tackling the zoonoses and food-borne diseases that threaten the public health of the European Community.
Texas plans to invest $3 billion in cancer research over the next 10 years and six scientists at The University of Texas Health Science Center at Houston are among the first to receive grants.The researchers, whose grants total $4.5 million, are working to protect girls from cervical cancer, to interrupt tumor growth at the molecular level and to develop a new approach for the treatment of colon cancer, among other cutting-edge projects.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center. APS is the leading multidisciplinary professional organization in the United States dedicated to advancing pain-related research, education, treatment and team-oriented professional practice.
Cancer Research UK-funded scientists have shown how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer, according to a study published in Nature.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FKC - Belleair Dialysis Center with elevated calcium levels.
| Patients with hypercalcemia | 107 |
| Hypercalcemia patient months | 867 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
| Patients with Serumphosphor | 119 |
| Patients with Serumphosphor less than 3.5 mg/dL | |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | |
| Patients with Serumphosphor greater than 7 mg/dL |
News Archive
Many risk factors for breast cancer are well studied and documented. Thus, scientists are sure by now that early first menstrual period, late onset of menopause and a family history of breast cancer are associated with an increased breast cancer risk.
To celebrate and reflect on the scientific achievements of one of Europe's most successful Networks of Excellence, and to launch the newly formed Med-Vet-Net Association — the future incarnation of the Med-Vet-Net partnership that will forge ahead with research tackling the zoonoses and food-borne diseases that threaten the public health of the European Community.
Texas plans to invest $3 billion in cancer research over the next 10 years and six scientists at The University of Texas Health Science Center at Houston are among the first to receive grants.The researchers, whose grants total $4.5 million, are working to protect girls from cervical cancer, to interrupt tumor growth at the molecular level and to develop a new approach for the treatment of colon cancer, among other cutting-edge projects.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center. APS is the leading multidisciplinary professional organization in the United States dedicated to advancing pain-related research, education, treatment and team-oriented professional practice.
Cancer Research UK-funded scientists have shown how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer, according to a study published in Nature.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 88 |
| Patient months included in arterial venous fistula and catheter summaries | 610 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
News Archive
Many risk factors for breast cancer are well studied and documented. Thus, scientists are sure by now that early first menstrual period, late onset of menopause and a family history of breast cancer are associated with an increased breast cancer risk.
To celebrate and reflect on the scientific achievements of one of Europe's most successful Networks of Excellence, and to launch the newly formed Med-Vet-Net Association — the future incarnation of the Med-Vet-Net partnership that will forge ahead with research tackling the zoonoses and food-borne diseases that threaten the public health of the European Community.
Texas plans to invest $3 billion in cancer research over the next 10 years and six scientists at The University of Texas Health Science Center at Houston are among the first to receive grants.The researchers, whose grants total $4.5 million, are working to protect girls from cervical cancer, to interrupt tumor growth at the molecular level and to develop a new approach for the treatment of colon cancer, among other cutting-edge projects.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center. APS is the leading multidisciplinary professional organization in the United States dedicated to advancing pain-related research, education, treatment and team-oriented professional practice.
Cancer Research UK-funded scientists have shown how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer, according to a study published in Nature.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | |
| Hospitalization Rate in facility | (Not Available) |
| Hospitalization Rate: Upper Confidence Limit | |
| Hospitalization Rate: Lower Confidence Limit |
News Archive
Many risk factors for breast cancer are well studied and documented. Thus, scientists are sure by now that early first menstrual period, late onset of menopause and a family history of breast cancer are associated with an increased breast cancer risk.
To celebrate and reflect on the scientific achievements of one of Europe's most successful Networks of Excellence, and to launch the newly formed Med-Vet-Net Association — the future incarnation of the Med-Vet-Net partnership that will forge ahead with research tackling the zoonoses and food-borne diseases that threaten the public health of the European Community.
Texas plans to invest $3 billion in cancer research over the next 10 years and six scientists at The University of Texas Health Science Center at Houston are among the first to receive grants.The researchers, whose grants total $4.5 million, are working to protect girls from cervical cancer, to interrupt tumor growth at the molecular level and to develop a new approach for the treatment of colon cancer, among other cutting-edge projects.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center. APS is the leading multidisciplinary professional organization in the United States dedicated to advancing pain-related research, education, treatment and team-oriented professional practice.
Cancer Research UK-funded scientists have shown how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer, according to a study published in Nature.
› Verified 6 days ago